1. Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Issue 20 (1st November 2018) Authors: Islam, Imadul; Yuan, Shendong; West, Christopher W.; Adler, Marc; Bothe, Ulrich; Bryant, Judi; Chang, Zheng; Chu, Kieu; Emayan, Kumar; Gualtieri, Giovanna; Ho, Elena; Light, David; Mallari, Cornell; Morser, John; Phillips, Gary; Schaefer, Caralee; Sukovich, Drew; Whitlow, Marc; Chen, Deborah; Buc... Journal: Bioorganic & medicinal chemistry letters Issue: Volume 28:Issue 20(2018) Page Start: 3372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reversible, orally available ADP receptor (P2Y12) antagonists Part I: Hit to lead process. Issue 9 (15th May 2018) Authors: Islam, Imadul; Yuan, Shendong; Wei, Robert G.; Xu, Wei; Morrissey, Michael; Mohan, Raju; Zheng, Dewan; DiMella, Andrea; Dunning, Laura; Snider, Michael; Subramanyam, Babu; Tseng, Jih-Lie; Bryant, Judi A.; Buckman, Brad O. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 28:Issue 9(2018) Page Start: 1459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗